Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.66 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.66 |
| ▸ | TST | Q16762 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PPM1A | P35813 | 2/20 | 0.39 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.34 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.34 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31676474 | 1.00 | MAPT (0.66) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL1974137 | 0.91 | MAPT (0.80) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL29804572 | 0.91 | MAPT (0.80) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL22099880 | 0.91 | MAPT (0.80) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL7805056 | 0.91 | MAPT (0.80) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL6429749 | 0.91 | MAPT (0.80) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL4394069 | 0.86 | MAPT (0.81) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL4574133 | 0.86 | MAPT (0.81) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL4394073 | 0.86 | MAPT (0.81) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL15153093 | 0.86 | MAPT (0.62) | MAPTHSPD1HSPE1TSTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150273066-A1 | CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS | RAMSCOR INC (US) | 2015-10-01 | — | — | US | claimed |
| US-20080038316-A1 | Conveniently implantable sustained release drug compositions | RAMSCOR, INC. | 2008-02-14 | — | — | US | claimed |
| US-6881278-B2 | Flux for solder paste | SHOWA DENKO K.K. (JP) | 2005-04-19 | — | — | US | claimed |
| US-20030200836-A1 | Flux for solder paste | SHOWA DENKO K.K. | 2003-10-30 | — | — | US | claimed |
| US-20020046627-A1 | Solder powder, flux, solder paste, soldering method, soldered circuit board, and soldered joint product | SHOWA DENKO K.K. (JP) | 2002-04-25 | — | — | US | claimed |
| US-20250367165-A1 | EMERGENCY EYE WASH | LEBRUN LABS LLC (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| US-20250262123-A1 | EMERGENCY EYE WASH | LEBRUN LABS LLC | 2025-08-21 | — | — | US | disclosed |
| US-20240115595-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | TEAM MEDICAL, LLC (US) | 2024-04-11 | — | — | US | disclosed |
| WO-2024055011-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | TEAM MEDICAL, LLC (US) | 2024-03-14 | — | — | WO | disclosed |
| US-10744202-B2 | Sustained release eye drop formulations | RAMSCOR, INC. (US) | 2020-08-18 | — | — | US | disclosed |
| US-20180289810-A1 | SUSTAINED RELEASE EYE DROP FORMULATIONS | RAMSCOR, INC. (US) | 2018-10-11 | — | — | US | disclosed |
| US-8541413-B2 | Sustained release eye drop formulations | RAMSCOR, INC. (US) | 2013-09-24 | — | — | US | disclosed |
| US-20110111006-A1 | CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS | RAMSCOR, INC. (US) | 2011-05-12 | — | — | US | disclosed |
| US-20090136445-A1 | SUSTAINED RELEASE EYE DROP FORMULATIONS | RAMSCOR, INC. | 2009-05-28 | — | — | US | disclosed |
| US-20080038316-A1 | Conveniently implantable sustained release drug compositions | RAMSCOR, INC. | 2008-02-14 | — | — | US | disclosed |
| US-6881278-B2 | Flux for solder paste | SHOWA DENKO K.K. (JP) | 2005-04-19 | — | — | US | disclosed |
| US-20030200836-A1 | Flux for solder paste | SHOWA DENKO K.K. | 2003-10-30 | — | — | US | disclosed |
| US-20020046627-A1 | Solder powder, flux, solder paste, soldering method, soldered circuit board, and soldered joint product | SHOWA DENKO K.K. (JP) | 2002-04-25 | — | — | US | disclosed |
| US-20010042779-A1 | Solder paste | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2001-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115595-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | RBM22, HNRNPUL2, HNRNPUL1 | MAPT 773/4885HSPD1 1126/4885HSPE1 1092/4885 |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | MAPT 953/4885HSPD1 1596/4885HSPE1 2003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.